Feds Quiz AstraZeneca PLC (AZN) Over Brilinta Clinical Trial
10/31/2013 1:13:14 PM
AstraZeneca is being investigated by U.S. authorities over a major clinical trial that was used to win marketing approval for its new heart drug Brilinta.
The British drugmaker said on Thursday it had received a civil investigative demand from the U.S. Department of Justice seeking documents and information regarding the so-called PLATO study.
Help employers find you! Check out all the jobs and post your resume.